A Monocenter Prospective Study to Evaluate the Efficacy of Peripherally Inserted Central Catheter to Tunnelled Central Catheter With Cuff in Home Parenteral Nutrition for Long-term Used.
NCT01840033 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2018-02-05
Summary
Home parenteral nutrition (HPN) is the reference treatment for anatomic or fonctionnal chronic intestinal failure. Nutritionnal catheter must follow two rules: low infection rate and be able to preserve the permeability of the central vein. Today, in europeen guidelines, two types of central devices are recommended: tunnelled central catheter with cuff and implanted ports. However, their insertion is not without risk. Since many years, we have seen a new generation of catheter - peripherally inserted central catheter (PICC line)- which have many advantage over other central catheter. ESPEN guidelines accept the use of PICC line in short and moderate-term for HPN, but no prospective study have look for long-term used in HPN.
The objective of our study is to evaluate in a prospective randomised monocenter study the no-inferiority of PICC line to tunnelled central catheter with cuff for serious catheter related-complications such as infection and thrombophlebitis for patient on HPN over 1 month of duration. The secondary objectives are to: evaluate the number of patients with at least one serious complications related in 1000 days of used, the rate of minors and majors complications, number of catheter inserted, the satisfaction of patients and doctors.
The study is held in CHU Nice and will be proposed to hospitalized patients who will need HPN. After consent, patients will be randomized to receive PICC Line (group A) of nutritional central catheter with cuff (group B). Echography of vessels will be held at the beginning, 3 months and 12 months. Follow-up will be conduct at regular interval (month 0-1-3-6-9-12). The duration of follow-up will be of 12 months and the global duration of the study will be 36 months. One major complication will conduct to withdrawal of the study. There will be 55 patients in each group.
Conditions
- Chronic Intestinal Failure
Interventions
- DEVICE
-
group Piccnut
Vessels echography will be systematically repeated at 3 months and 12 months for thrombosis research. Follow-up visit will be held at 1,3,6,9 and 12 months. At every step, major and minor complications will be noted by the investigators.
- DEVICE
-
Tunnelled nutritional central catheter
After consent, patients will be randomised to PICC Line (group A) or tunnelled nutritional central catheter with cuff (group B). Duration of inclusion will be 24 months. After randomisation, patients will have catheter inserted by a competent radiologist following an echography. Radiologist will have to answer a questionnaire and doctors will note any catheter-related complications. After that, vessels echography will be systematically repeated at 3 months and 12 months for thrombosis research. Follow-up visit will be held at 1,3,6,9 and 12 months. At every step, major and minor complications will be noted by the investigators.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nice
lead OTHER
Principal Investigators
-
HEBUTERNE Xavier, PhD · CHU de Nice, Hôpital Archet, Pôle Digestif, 151 route de saint-antoine de ginestière 06200 Nice
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- France
Study Locations
More Related Trials
-
SecurAcath Versus Statlock for PICC Securement
NCT02311127 ·Status: COMPLETED ·Phase: NA
-
Tunneled Peripherally Inserted Central Catheter (PICC) in Adult Patients and Associated Outcomes
NCT06365528 ·Status: RECRUITING ·Phase: NA
-
Iterative PICC Placement Versus Long Term Device
NCT02784730 ·Status: WITHDRAWN ·Phase: PHASE3
-
Clinical Pharmacy for Patients with a PICC Line
NCT04359056 ·Status: COMPLETED ·Phase: NA
-
Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates
NCT03474978 ·Status: RECRUITING ·Phase: NA
-
Lock sOlutiOnS for Epicutaneo-caval Catheters in Neonates: a "LOOSEN" Pilot Study
NCT05729321 ·Status: UNKNOWN
-
Clinical Evaluation of the VIPUN Balloon Catheter 0.2 in Critically Ill Patients
NCT03512145 ·Status: COMPLETED ·Phase: NA
-
Catheter Salvage in Intestinal Failure Patients
NCT03222232 ·Status: COMPLETED
-
A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval Filter System
NCT02674672 ·Status: COMPLETED ·Phase: NA
-
A Retrospective, Observational, Monocenter, Study to Describe the Utilization and Overall Safety and Performance of POLYSITE®/SEESITE® Implantable Ports
NCT05519787 ·Status: COMPLETED
-
Arrow Chloragard Peripherally-Inserted Central Catheters (PICC) Study
NCT03019302 ·Status: UNKNOWN ·Phase: NA
-
COMPLI-PICC: Study on Picclines' Complications
NCT03017911 ·Status: COMPLETED
-
Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports
NCT00921141 ·Status: COMPLETED
-
Port Will be Flushed Every 3 Months Instead of Every 4-6 Wks, as Recommended by Port Manufacturer.
NCT01047644 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Tetrasodium EDTA Catheter Lock Solution for Patients on HTPN
NCT04067245 ·Status: UNKNOWN ·Phase: NA
-
Midline Catheter and Its Impact on Central Lines Removal in ICU
NCT03675711 ·Status: TERMINATED ·Phase: NA
-
A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters
NCT00395876 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Taurolidin on Prevention of Bloodstream Infection
NCT00545831 ·Status: TERMINATED ·Phase: NA
-
Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections
NCT06660641 ·Status: COMPLETED ·Phase: NA
-
A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters
NCT00396318 ·Status: COMPLETED ·Phase: PHASE3
-
The Clinical Efficacy of Midline Catheters
NCT03457259 ·Status: COMPLETED ·Phase: NA
-
Citrate 4% Versus Heparinised Saline in Preventing Peripherally Inserted Central Catheter (PICC) Occlusions
NCT03114722 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites
NCT04900740 ·Status: UNKNOWN ·Phase: NA
-
Comparison Between Sutureless Devices for PICC and a New System KT FIX PLUS
NCT02805335 ·Status: UNKNOWN ·Phase: NA
-
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
NCT06822426 ·Status: RECRUITING ·Phase: PHASE3